Harrow's fair value of $73.25 implies 104% upside from current levels. Click here to see why the stock is a Buy.

The conversation around sorghum as a food ingredient is not new; it’s actually several thousand years old, ...

The shampoo aisle can be confusing. Especially when shampoos can range in price from under $10 at the drugstore to north of ...

The ruling holds the law exceeds Congress' authority under the tax power and the Necessary and Proper Clause. But it does not ...

What low-GWP propellants mean for inhaler design, manufacturing, and packaging.

Darko The recent decision of the Supreme Court in Gorni v Vodafone Ghana Ltd & Others signals an important shift in the ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Speed to market wont guarantee success in todays launch environment. Anticipating what prescribers, patients and payers will ...

High-dose vaccine tied to roughly 20% lower risk of Alzheimer's dementia ...

CTEXLI approved by FDA for CTX; LIVMARLI approved in Japan for PFIC and Alagille syndrome with partner Takeda; and a single ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...